CDKN2A and atherosclerosis: Although the latter study did not clearly identify the cell type involved, the study of Kuo et al. showed that bone marrow-specific reduced CDKN2A expression (including p16INK4a and p19ARF) is required and sufficient to accelerate atherosclerosis formation in ldlr−/− mice [10].